The pathophysiologic roles of TRPM 7 channel

Korean Journal of Physiology and Pharmacology

Volumn 18, Issue 1, 2014, Pages 15-23

  Park, Hyun Soo ^a   Hong, Chansik ^b   Kim, Byung Joo ^a   So, Insuk ^b  

^a Pusan National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Disease; Ion channel; Transient receptor potential melastatin 7; TRPM7

Indexed keywords

CALCIUM; MAGNESIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7;

AMYOTROPHIC LATERAL SCLEROSIS; BIOPHYSICS; BRAIN ISCHEMIA; CANCER GROWTH; CELL DEATH; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DISEASE; DEMENTIA; HUMAN; HYPERTENSION; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE POTENTIAL; NONHUMAN; OSSIFICATION; PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ZEBRA FISH;

EID: 84896507777     PISSN: 12264512     EISSN: 20933827     Source Type: Journal    
DOI: 10.4196/kjpp.2014.18.1.15     Document Type: Review

References (101)

1. Doyle JL, Stubbs L. Ataxia, arrhythmia and ion-channel gene defects. Trends Genet. 1998;14:92-98. (Pubitemid 28165106)
2. Kunzelmann K. Ion channels and cancer. J Membr Biol. 2005;205:159-173. (Pubitemid 41803693)
3. Farias LM, Ocaña DB, Díaz L, Larrea F, Avila-Chávez E, Cadena A, Hinojosa LM, Lara G, Villanueva LA, Vargas C, Hernández- Gallegos E, Camacho-Arroyo I, Dueñas-González A, Pérez-Cárdenas E, Pardo LA, Morales A, Taja-Chayeb L, Escamilla J, Sánchez-Peña C, Camacho J. Ether a go-go potassium channels as human cervical cancer markers. Cancer Res. 2004;64:6996-7001. (Pubitemid 39331009)
4. Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda). 2004;19:285-292. (Pubitemid 39472640)
5. + channels. EMBO J. 1999;18:5540-5547. (Pubitemid 29486373)
6. Schwarz EC, Wissenbach U, Niemeyer BA, Strauss B, Philipp SE, Flockerzi V, Hoth M. TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium. 2006;39:163-173. (Pubitemid 43013848)
7. Sanchez MG, Sanchez AM, Collado B, Malagarie-Cazenave S, Olea N, Carmena MJ, Prieto JC, Diaz-Laviada II. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur J Pharmacol. 2005;515:20-27. (Pubitemid 40779263)
8. Bödding M. TRP proteins and cancer. Cell Signal. 2007;19:617-624. (Pubitemid 46107813)
9. Clapham DE. TRP channels as cellular sensors. Nature. 2003;426:517-524. (Pubitemid 37522633)
10. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium. 2005;38:233-252. (Pubitemid 41283262)
11. Ramsey IS, Delling M, Clapham DE. An introduction to TRP channels. Annu Rev Physiol. 2006;68:619-647.
12. Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol. 2011;12:218.
13. Dhennin-Duthille I, Gautier M, Faouzi M, Guilbert A, Brevet M, Vaudry D, Ahidouch A, Sevestre H, Ouadid-Ahidouch H. High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem. 2011;28:813-822.
14. Yee NS, Chan AS, Yee JD, Yee RK. TRPM7 and TRPM8 ion channels in pancreatic adenocarcinoma: potential roles as cancer biomarkers and targets. Scientifica. 2012:1.
15. Schlingmann KP, Waldegger S, Konrad M, Chubanov V, Gudermann T. TRPM6 and TRPM7-Gatekeepers of human magnesium metabolism. Biochim Biophys Acta. 2007;1772:813-821. (Pubitemid 47176377)
16. Paravicini TM, Chubanov V, Gudermann T. TRPM7: a unique channel involved in magnesium homeostasis. Int J Biochem Cell Biol. 2012;44:1381-1384.
17. Mederosy Schnitzler M, Wäring J, Gudermann T, Chubanov V. Evolutionary determinants of divergent calcium selectivity of TRPM channels. FASEB J. 2008;22:1540-1551. (Pubitemid 351656794)
18. Mei ZZ, Xia R, Beech DJ, Jiang LH. Intracellular coiled-coil domain engaged in subunit interaction and assembly of melastatin-related transient receptor potential channel 2. J Biol Chem. 2006;281:38748-38756. (Pubitemid 46042002)
19. Bae CY, Sun HS. TRPM7 in cerebral ischemia and potential target for drug development in stroke. Acta Pharmacol Sin. 2011;32:725-733.
20. Yamaguchi H, Matsushita M, Nairn AC, Kuriyan J. Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol Cell. 2001;7:1047-1057. (Pubitemid 32525751)
21. Monteilh-Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol. 2003;121:49-60. (Pubitemid 36133936)
22. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A. LTRPC7 is a Mg. ATP-regulated divalent cation channel required for cell viability. Nature. 2001;411:590-595. (Pubitemid 32531406)
23. Demeuse P, Penner R, Fleig A. TRPM7 channel is regulated by magnesium nucleotides via its kinase domain. J Gen Physiol. 2006;127:421-434.
24. Runnels LW, Yue L, Clapham DE. The TRPM7 channel is inactivated by PIP (2) hydrolysis. Nat Cell Biol. 2002;4:329-336. (Pubitemid 34521027)
25. Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ J. 2011;75:237-245.
26. Schmitz C, Dorovkov MV, Zhao X, Davenport BJ, Ryazanov AG, Perraud AL. The channel kinases TRPM6 and TRPM7 are functionally nonredundant. J Biol Chem. 2005;280:37763-37771. (Pubitemid 41642386)
27. Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol. 2006;127:525-537.
28. 2+-inhibited cation (MIC) channels. J Gen Physiol. 2002;119:487-507. (Pubitemid 34522292)
29. Parnas M, Peters M, Dadon D, Lev S, Vertkin I, Slutsky I, Minke B. Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium. 2009;45:300-309.
30. Chen HC, Xie J, Zhang Z, Su LT, Yue L, Runnels LW. Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS One. 2010;5:e11161.
31. Chen X, Numata T, Li M, Mori Y, Orser BA, Jackson MF, Xiong ZG, MacDonald JF. The modulation of TRPM7 currents by nafamostat mesilate depends directly upon extracellular concentrations of divalent cations. Mol Brain. 2010;3:38.
32. Chubanov V, Mederosy Schnitzler M, Meißner M, Schäfer S, Abstiens K, Hofmann T, Gudermann T. Natural and synthetic modulators of SK (K (ca) 2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br J Pharmacol. 2012;166:1357-1376.
33. Zierler S, Yao G, Zhang Z, Kuo WC, Pörzgen P, Penner R, Horgen FD, Fleig A. Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels. J Biol Chem. 2011;286:39328-39335.
34. Qin X, Yue Z, Sun B, Yang W, Xie J, Ni E, Feng Y, Mahmood R, Zhang Y, Yue L. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels. Br J Pharmacol. 2013;168:1294-1312.
35. 2+ permeability and pH sensitivity in TRPM6 and TRPM7. J Biol Chem. 2007;282:25817-25830. (Pubitemid 47372822)
36. Jiang J, Li M, Yue L. Potentiation of TRPM7 inward currents by protons. J Gen Physiol. 2005;126:137-150. (Pubitemid 41124190)
37. Jiang J, Li MH, Inoue K, Chu XP, Seeds J, Xiong ZG. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res. 2007;67:10929-10938. (Pubitemid 350145922)
38. Numata T, Okada Y. Proton conductivity through the human TRPM7 channel and its molecular determinants. J Biol Chem. 2008;283:15097-15103.
39. 2+-nucleotide- regulated channel-kinase TRPM7. Handb Exp Pharmacol. 2007; (179): 313-328.
40. Hermosura MC, Nayakanti H, Dorovkov MV, Calderon FR, Ryazanov AG, Haymer DS, Garruto RM. A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proc Natl Acad Sci U S A. 2005;102:11510-11515. (Pubitemid 41153850)
41. Fonfria E, Murdock PR, Cusdin FS, Benham CD, Kelsell RE, McNulty S. Tissue distribution profiles of the human TRPM cation channel family. J Recept Signal Transduct Res. 2006;26:159-178.
42. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science. 2001;291:1043-1047. (Pubitemid 32157413)
43. He Y, Yao G, Savoia C, Touyz RM. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res. 2005;96:207-215. (Pubitemid 40209368)
44. 2+ entry pathway in human retinoblastoma cells. J Pharmacol Sci. 2004;95:403-419. (Pubitemid 39237469)
45. Elizondo MR, Arduini BL, Paulsen J, MacDonald EL, Sabel JL, Henion PD, Cornell RA, Parichy DM. Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr Biol. 2005;15:667-671.
46. Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M. A key role for TRPM7 channels in anoxic neuronal death. Cell. 2003;115:863-877. (Pubitemid 38058498)
47. Abed E, Moreau R. Importance of melastatin-like transient receptor potential 7 and cations (magnesium, calcium) in human osteoblast-like cell proliferation. Cell Prolif. 2007;40:849-865. (Pubitemid 350135206)
48. 2+ homeostasis. Science. 2008;322:756-760.
49. Liu W, Su LT, Khadka DK, Mezzacappa C, Komiya Y, Sato A, Habas R, Runnels LW. TRPM7 regulates gastrulation during vertebrate embryogenesis. Dev Biol. 2011;350:348-357.
50. 2+ homeostasis in mammals. Nat Commun. 2010;1:109.
51. Su LT, Agapito MA, Li M, Simonson WT, Huttenlocher A, Habas R, Yue L, Runnels LW. TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J Biol Chem. 2006;281:11260-11270. (Pubitemid 43855551)
52. Clark K, Langeslag M, van Leeuwen B, Ran L, Ryazanov AG, Figdor CG, Moolenaar WH, Jalink K, van Leeuwen FN. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J. 2006;25:290-301. (Pubitemid 43152850)
53. Wei C, Wang X, Chen M, Ouyang K, Song LS, Cheng H. Calcium flickers steer cell migration. Nature. 2009;457:901-905.
54. Krapivinsky G, Mochida S, Krapivinsky L, Cibulsky SM, Clapham DE. The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron. 2006;52:485-496. (Pubitemid 44679819)
55. Oancea E, Wolfe JT, Clapham DE. Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ Res. 2006;98:245-253.
56. Inoue R, Jensen LJ, Shi J, Morita H, Nishida M, Honda A, Ito Y. Transient receptor potential channels in cardiovascular function and disease. Circ Res. 2006;99:119-131. (Pubitemid 44297035)
57. Sah R, Mesirca P, Mason X, Gibson W, Bates-Withers C, Vanden Boogert M, Chaudhuri D, Pu WT, Mangoni ME, Clapham DE. Timing of myocardial trpm7 deletion during cardiogenesis variably disrupts adult ventricular function, conduction, and repolarization. Circulation. 2013;128:101-114.
58. Sah R, Mesirca P, Vanden Boogert M, Rosen J, Mably J, Mangoni ME, Clapham DE. Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity. Proc Natl Acad Sci U S A. 2013;110:E3037-E3046.
59. Kim BJ, Lim HH, Yang DK, Jun. JY, Chang IY, Park CS, So I, Stanfield PR, Kim KW. Melastatin-type transient receptor potential channel 7 is required for intestinal pacemaking activity. Gastroenterology. 2005;129:1504-1517. (Pubitemid 41597392)
60. Yue D, Wang Y, Xiao JY, Wang P, Ren CS. Expression of TRPC6 in benign and malignant human prostate tissues. Asian J Androl. 2009;11:541-547.
61. Santoni G, Farfariello V, Amantini C. TRPV channels in tumor growth and progression. Adv Exp Med Biol. 2011;704:947-967.
62. Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ. Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol. 2001;19:568-576. (Pubitemid 32112872)
63. Tsavaler L, Shapero MH, Morkowski S, Laus R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res. 2001;61:3760-3769. (Pubitemid 32694990)
64. Dou Y, Li Y, Chen J, Wu S, Xiao X, Xie S, Tang L, Yan M, Wang Y, Lin J, Zhu W, Yan G. Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7. Oncol Lett. 2013;5:1010-1016.
65. Kim BJ, Park EJ, Lee JH, Jeon JH, Kim SJ, So I. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer. Cancer Sci. 2008;99:2502-2509.
66. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol. 2009;297:C493-C502.
67. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296:2939-2946. (Pubitemid 46023453)
68. Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ. Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis. Stroke. 2013;44:1360-1368.
69. Kristián T, Siesjö BK. Calcium in ischemic cell death. Stroke. 1998;29:705-718. (Pubitemid 28145802)
70. Sattler R, Tymianski M. Molecular mechanisms of calciumdependent excitotoxicity. J Mol Med (Berl). 2000;78:3-13.
71. 2+ signaling, cell death and stroke. Trends Neurosci. 2006;29:75-81. (Pubitemid 43202596)
72. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623-634.
73. Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev. 2000; (2): CD001928.
74. 2+ overload indicates early neuronal injury which precedes staining with viability indicators. Brain Res. 1993;607:319-323. (Pubitemid 23104982)
75. 2+ influx elicited by glutamate: role in neuronal death. Mol Pharmacol. 1989;36:106-112. (Pubitemid 19191266)
76. Randall RD, Thayer SA. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J Neurosci. 1992;12:1882-1895.
77. Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies-the need for new approaches. Cerebrovasc Dis. 2004;17(Suppl 1):153-166. (Pubitemid 38032534)
78. Lipski J, Park TI, Li D, Lee SC, Trevarton AJ, Chung KK, Freestone PS, Bai JZ. Involvement of TRP-like channels in the acute ischemic response of hippocampal CA1 neurons in brain slices. Brain Res. 2006;1077:187-199.
79. Sun HS, Jackson MF, Martin LJ, Jansen K, Teves L, Cui H, Kiyonaka S, Mori Y, Jones M, Forder JP, Golde TE, Orser BA, Macdonald JF, Tymianski M. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci. 2009;12:1300-1307.
80. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369. (Pubitemid 37430168)
81. Resnick LM, Laragh JH, Sealey JE, Alderman MH. Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med. 1983;309:888-891. (Pubitemid 13014029)
82. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension. 1991;17:951-957.
83. Resnick LM. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med. 1992;93:11S-20S.
84. Aviv A. Salt consumption, reactive oxygen species and cardiovascular ageing: a hypothetical link. J Hypertens. 2002;20:555-559. (Pubitemid 34913687)
85. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 2004;287:H435-H446. (Pubitemid 38960790)
86. Rubin H. The logic of the Membrane, Magnesium, Mitosis (MMM) model for the regulation of animal cell proliferation. Arch Biochem Biophys. 2007;458:16-23. (Pubitemid 46186224)
87. 2+ entry in vascular smooth muscle cells. Circulation. 1997;95:2567-2572. (Pubitemid 27233123)
88. Touyz RM, He Y, Montezano AC, Yao G, Chubanov V, Gudermann T, Callera GE. Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2006;290:R73-78.
89. Voets T, Nilius B. Modulation of TRPs by PIPs. J Physiol. 2007;582:939-944. (Pubitemid 47104330)
90. 2+ absorption. J Biol Chem. 2004;279:19-25. (Pubitemid 38044794)
91. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol. 2008;294:H1103-1118. (Pubitemid 351468705)
92. Sontia B, Montezano AC, Paravicini T, Tabet F, Touyz RM. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertension. 2008;51:915-921. (Pubitemid 351654704)
93. 2+ transport in vascular smooth muscle cells in genetic hypertension. Hypertension. 1999;34:442-449. (Pubitemid 29426761)
94. 2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats. J Hypertens. 2003;21:337-344. (Pubitemid 36269705)
95. Dietrich A, Mederos Y Schnitzler M, Gollasch M, Gross V, Storch U, Dubrovska G, Obst M, Yildirim E, Salanova B, Kalwa H, Essin K, Pinkenburg O, Luft FC, Gudermann T, Birnbaumer L. Increased vascular smooth muscle contractility in TRPC6-/-mice. Mol Cell Biol. 2005;25:6980-6989. (Pubitemid 41105898)
96. Mathar I, Vennekens R, Meissner M, Kees F, Van der Mieren G, Camacho Londoño JE, Uhl S, Voets T, Hummel B, van den Bergh A, Herijgers P, Nilius B, Flockerzi V, Schweda F, Freichel M. Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest. 2010;120:3267-3279.
97. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335-346.
98. Vennekens R. Emerging concepts for the role of TRP channels in the cardiovascular system. J Physiol. 2011;589:1527-1534.
99. Shaw PJ. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry. 2005;76:1046-1057. (Pubitemid 41081274)
100. Hara K, Kokubo Y, Ishiura H, Fukuda Y, Miyashita A, Kuwano R, Sasaki R, Goto J, Nishizawa M, Kuzuhara S, Tsuji S. TRPM7 is not associated with amyotrophic lateral sclerosis-parkinsonism dementia complex in the Kii peninsula of Japan. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:310-313.
101. Elizondo MR, Arduini BL, Paulsen J, MacDonald EL, Sabel JL, Henion PD, Cornell RA, Parichy DM. Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr Biol. 2005;15:667-671.